AMH(AMH)
AMH
Q3 2026 EPS Estimate
$0.18
Jul 30, 2026 · Reports after close
Revenue Estimate
$467M
FY2026E EPS$0.94
FY2027E EPS$0.80
Analyst Sentiment
Wall St. Consensus
Buy31 analysts·High coverage
65
Score
18 Buy (58%)13 Hold (42%)0 Sell (0%)
Rating Breakdown
Strong Buy
00%
Buy
1858%
Hold
1342%
Sell
00%
Strong Sell
00%
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price Target Expectations
Bear
$32.00
-5.9%
Consensus
$35.00
+3.0%
Bull
$39.00
+14.7%
12-Month Target Range31 analysts
$32.00$35.00$39.00
Current $33.99Consensus
Current Price
$33.99
Upside to Consensus
$1.01
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
Earnings & Revenue Estimates
Forward Growth Estimates (YoY)
FY2027
Rev+3.55%
EPS-14.19%
FY2028
Rev+5.02%
EPS-13.70%
Raw consensus estimates (low / average / high) from covering analysts.
Annual
| Metric | FY2026E | FY2027E | FY2028E |
|---|---|---|---|
| Revenue Avg | $1.90B | $1.96B | $2.06B |
| Low | $1.89B | $1.93B | $2.06B |
| High | $1.91B | $1.99B | $2.06B |
| EBITDA Avg | $1.43B | $1.48B | $1.56B |
| Low | $1.43B | $1.46B | $1.56B |
| High | $1.44B | $1.51B | $1.56B |
| EBIT Avg | $974M | $1.01B | $1.06B |
| Low | $969M | $993M | $1.06B |
| High | $979M | $1.02B | $1.06B |
| Net Income Avg | $348M | $298M | $278M |
| Low | $345M | $295M | $219M |
| High | $351M | $301M | $309M |
| EPS Avg | $0.94 | $0.80 | $0.69 |
| Low | $0.93 | $0.80 | $0.59 |
| High | $0.95 | $0.81 | $0.83 |
| Analysts (Rev / EPS) | 9 / 5 | 9 / 6 | 5 / 5 |
Quarterly
| Metric | Q2 2026 | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $467M | $488M | $470M | $489M | $484M | $507M | $488M | $499M |
| Low | $462M | $478M | $460M | $479M | $474M | $496M | $478M | $488M |
| High | $471M | $495M | $477M | $496M | $491M | $514M | $495M | $506M |
| EBITDA Avg | $352M | $368M | $355M | $370M | $366M | $383M | $369M | $377M |
| Low | $349M | $361M | $347M | $362M | $358M | $375M | $361M | $369M |
| High | $356M | $374M | $360M | $375M | $371M | $388M | $374M | $382M |
| EBIT Avg | $240M | $250M | $241M | $251M | $249M | $260M | $251M | $256M |
| Low | $237M | $245M | $236M | $246M | $243M | $255M | $245M | $251M |
| High | $242M | $254M | $245M | $255M | $252M | $264M | $254M | $260M |
| Net Income Avg | $67M | $67M | $72M | $67M | $71M | $74M | $74M | $73M |
| Low | $66M | $66M | $70M | $66M | $69M | $72M | $72M | $71M |
| High | $68M | $69M | $73M | $69M | $72M | $76M | $75M | $74M |
| EPS Avg | $0.18 | $0.19 | $0.20 | $0.18 | $0.19 | $0.20 | $0.20 | $0.20 |
| Low | $0.18 | $0.18 | $0.19 | $0.18 | $0.19 | $0.20 | $0.20 | $0.19 |
| High | $0.19 | $0.19 | $0.20 | $0.19 | $0.20 | $0.21 | $0.21 | $0.20 |
| Analysts (Rev / EPS) | 7 / 5 | 7 / 4 | 4 / 2 | 4 / 2 | 3 / 1 | 3 / 1 | 3 / 2 | 2 / 3 |